novo nordisk glp-1 drug Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say McKee's proposed FY2027 budget drops
Description
And heres the thing: the research shows they work just as well for menopausal and perimenopausal women as they do for younger women
Limiting therapy duration: 63% are placing caps on how long a member can use the medication
Where Can I Learn More About GLP-1s
As a lower-cost way for a plan sponsor to help employees access medications that are available DTC, this approach could make it feasible to offer a benefit for the first time or to continue some form of support
